Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.
Martina SebökIsabel C HostettlerEmanuela KellerIlari M RautalinBert A CoertWilliam Peter VandertopRené PostAli SardehaMaud A TjerkstraLuca RegliDagmar VerbaanMenno R GermansPublished in: International journal of stroke : official journal of the International Stroke Society (2021)
In this multicenter study, the prehemorrhage acetylsalicylic acid use in aneurysmal subarachnoid hemorrhage patients was independently associated with poor clinical outcome at six months. Thrombocyte transfusion was not associated with the rebleed rate or poor clinical outcome at six months.